Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4
Closed -$1.1K 4959
2025
Q1
$1.1K Hold
4
﹤0.01% 3313
2024
Q4
$3.82K Buy
+4
New +$5.24K ﹤0.01% 2900
2023
Q1
Hold
0
-$43K 3803
2022
Q4
Hold
0
2347
2022
Q3
Hold
0
2484
2022
Q2
Hold
0
2268
2022
Q1
Hold
0
2268
2019
Q1
Hold
0
1176

Other funds holding GNPX

IFP Advisors's GNPX Position: Q2 2025 in Review

IFP Advisors sold out of Genprex (GNPX) in Q2 2025, closing a stake of 4 shares — an estimated $1.1K sold.

IFP Advisors first reported a position in GNPX in Q4 2024 and held it in 2 quarters. The position peaked at $3.82K in Q4 2024. 15 funds tracked by Wall St. Rank hold GNPX as of Q2 2025.

  • IFP Advisors reported no remaining Genprex position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 4 Genprex shares in Q2 2025, an estimated $1.1K.
  • IFP Advisors first reported a position in Genprex in Q4 2024 and held it in 2 quarters.
  • IFP Advisors's Genprex position peaked at $3.82K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Genprex as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.